To receive the Femtech World newsletter, sign up here.
News
Start-up raises US$25m to develop treatment for PCOS-related infertility
The treatment works by lowering androgen production, which can restore ovulation in women with PCOS

The medical device start-up May Health has raised US$25m in funding to develop an “innovative” treatment to restore ovulation in women with PCOS.
PCOS is one of the most common causes of female infertility, affecting 10 per cent of women globally.
In women with PCOS, there is a local disregulation of androgens as compared to oestrogens in the ovary, leading to inconsistent ovulation.
The condition is also associated with increased insulin resistance, Type 2 diabetes, heart disease and stroke.
May Health’s investigational treatment works by lowering androgen production, which can restore ovulation.
The one-time in-office procedure aims to induce ovulation through targeted ablation of ovarian tissue using radiofrequency energy.
The financing round, co-led by Bpifrance and Trill Impact, is hoped to advance the company’s therapy through a clinical study which will evaluate the treatment’s potential to address PCOS-related infertility.
“This financing allows May Health to continue delivering upon our mission to become a leader in global women’s health and transform treatment for patients with PCOS,” Anne Morrissey, CEO of May Health, told Femtech World.
“We are very grateful to each of the investors who have continued to support us on our journey to offer more for women living with PCOS, an area of medicine that has been underserved with few treatment options.
“There has been a severe unmet need for more accessible options, and this new funding will allow us to continue to advance our US pivotal study to investigate the potential of Ovarian Rebalancing in women with infertility caused by PCOS.”
She added: “We’re committed to bringing a modern approach to the millions of women looking for alternative options to achieve pregnancy in a more natural manner.”
Dr Robert Auerbach, OB/GYN and chairman of the May Health board, said: “For years, women with PCOS who struggle with infertility have sought alternative treatment options that go beyond IVF and laparoscopic ovarian drilling.
“Our team is working to develop a simple and safe procedure that can activate natural ovulation and help women regain their ability to grow their families.
“We’re thankful to our investment partners for their support and look forward to further research of Ovarian Balancing in the REBALANCE Study.”
Nina Rawal, co-head and partner at Trill Impact Ventures, shared: “We see May Health as a great example of a company where commercial opportunity and impact go hand in hand.
“Trill Impact is excited to collaborate with the May Health team and its strong shareholders to bring their innovative product to women who have suffered from a lack of treatment options for too long.”
Jean-François Morin, investment director at Bpifrance, said May Health is charting a “new path” in fertility care.
“We are thrilled to support the company’s effort to bring its new approach to women with PCOS, including advancing it in the pivotal REBALANCE Study,” he explained.
“With its unique mechanism of action, May Health’s device has the potential to significantly improve the lives of patients with PCOS, including but not limited to related infertility issues.
“We are committed to supporting May Health to become a leader in the PCOS space.”
Fertility
Toxins and climate harms having ‘alarming’ effect on fertility, research warns

Simultaneous exposure to toxic chemicals and climate-related heat may be worsening fertility harms across humans and wildlife, research suggests.
The review of scientific literature looks at how endocrine-disrupting chemicals, often found in plastic, together with climate-related effects such as heat stress, are each linked to lower fertility and fecundity, meaning the ability to reproduce, across species including humans, wildlife and invertebrates.
Though the reproductive harms of each issue in isolation are well studied, there is little research on what happens when living organisms are exposed to both.
“Together, the two issues are likely to pose a greater threat to fertility, and the additive effect is “alarming”, said Susanne Brander, a study lead author and courtesy faculty at Oregon State University.
“You’re not just getting exposed to one, but two, stressors at the same time that both may affect your fertility, and in turn the overall impact is going to be a bit worse,” Brander said.
The paper looked at 177 studies.
Shanna Swan, a co-author on the new paper, co-produced a 2017 study that found sperm levels among men in western countries had fallen by more than 50 per cent over four decades. Other research has suggested human fertility has been declining at a similar rate.
The University of Washington’s Institute for Health Metrics and Evaluation has previously said the world was approaching a “low-fertility future”, with more than three quarters of countries below replacement rate by 2050.
The new paper’s authors focused on the effects of endocrine-disrupting chemicals and substances, including microplastics, bisphenol, phthalates and PFAS.
These are thought to cause a range of serious reproductive problems, disrupt hormones and be a potential driver of falling fertility.
Brander said the harms linked to these chemicals are often similar across organisms, from invertebrates to humans.
Phthalates, for example, have been linked to altered sperm shape in invertebrates, spermatogenesis in rodents, meaning sperm production, and reduced sperm counts in humans.
PFAS are also thought to affect sperm quality, and both have been linked to hormone disruption.
The chemicals are widespread in consumer goods, so people are often regularly exposed.
Meanwhile, previous research has shown how rising temperatures, lower oxygen levels and heat stress, among other effects linked to climate change, may also worsen infertility.
Heat stress has been found to affect human hormones, and is linked to spermatogenesis in rodents and bulls.
Research shows temperature also plays a role in sex determination in fish, reptiles and amphibians.
The species has evolved to choose which sex it produces in part based on temperature, and the heating planet can “push it too far in one direction or the other, which overrides that evolutionary benefit”, Brander said.
Similarly, many endocrine disruptors may alter environmental sex determination.
The study set out some of the overlapping effects of chemical exposure and climate change across taxonomic groups, from invertebrates to humans.
In birds, for example, exposure to increased temperature, PFAS, organochlorines and pyrethroids may each individually cause abnormal sperm, increased fledgling mortality, abnormal testes and population decline.
“What happens if they’re exposed to more than one of those stressors at the same time? There has been little exploration of that question.
“Even if there have not been a lot of studies looking at these simultaneously, if you have two different factors that both cause the same adverse effect, then there’s a likelihood that they are going to be additive,” Brander said.
Katie Pelch, a senior scientist with the Natural Resources Defense Council nonprofit, who was not part of the study, said the authors had reviewed high-quality science.
She said she wanted to see more examples of the overlap in impacts, but agreed with the overall premise.
“It is likely [multiple stressors] would have an additive effect, at very least, even if they have different mechanisms of harm,” Pelch added.
The solution to the systemic problems would involve tackling climate change and reducing the use of toxic chemicals.
The study cites the global reduction in the use of DDT and PCBs achieved under the Stockholm Convention as an example of an effective measure, but Brander said much more is needed.
“There is enough evidence in both areas to act to reduce our impact on the planet,” she said.
Pregnancy
Home blood pressure checks could lower heart risks for new mothers – study
Fertility
Researcher explores weight loss jab impact on PCOS
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Entrepreneur4 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Opinion4 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health6 days agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says















5 Comments